- Filed
- Mar 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 53.32M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 38.06M sh |
| Capex | FY 2024 · Dec 31, 2023 | $33.12M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $13.83M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $257.69M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $23.44M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.67M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $84.39M |
| Current Assets | FY 2024 · Dec 31, 2023 | $36.4M |
| Total Assets | FY 2024 · Dec 31, 2023 | $243.41M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$1.22 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$1.22 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $39.42M |
| Net Income | FY 2024 · Dec 31, 2023 | −$46.42M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$37.4M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $2.02M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $184.7M |